Celldex Therapeutics, Inc.

NasdaqCM:CLDX 株式レポート

時価総額:US$1.9b

Celldex Therapeutics マネジメント

マネジメント 基準チェック /24

Celldex Therapeuticsの CEO はAnthony Marucciで、 May2003年に任命され、 の在任期間は 21.5年です。 の年間総報酬は$ 8.36Mで、 8.6%給与と91.4%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.061%を直接所有しており、その価値は$ 1.13M 。経営陣と取締役会の平均在任期間はそれぞれ8.4年と11.8年です。

主要情報

Anthony Marucci

最高経営責任者

US$8.4m

報酬総額

CEO給与比率8.6%
CEO在任期間21.5yrs
CEOの所有権0.06%
経営陣の平均在職期間8.4yrs
取締役会の平均在任期間11.8yrs

経営陣の近況

Here's Why Celldex Therapeutics, Inc.'s (NASDAQ:CLDX) CEO Compensation Is The Least Of Shareholders' Concerns

Jun 07
Here's Why Celldex Therapeutics, Inc.'s (NASDAQ:CLDX) CEO Compensation Is The Least Of Shareholders' Concerns

Recent updates

Here's Why Celldex Therapeutics, Inc.'s (NASDAQ:CLDX) CEO Compensation Is The Least Of Shareholders' Concerns

Jun 07
Here's Why Celldex Therapeutics, Inc.'s (NASDAQ:CLDX) CEO Compensation Is The Least Of Shareholders' Concerns

We Think Celldex Therapeutics (NASDAQ:CLDX) Can Afford To Drive Business Growth

Jun 05
We Think Celldex Therapeutics (NASDAQ:CLDX) Can Afford To Drive Business Growth

We Think Celldex Therapeutics (NASDAQ:CLDX) Can Afford To Drive Business Growth

Jul 07
We Think Celldex Therapeutics (NASDAQ:CLDX) Can Afford To Drive Business Growth

An Intrinsic Calculation For Celldex Therapeutics, Inc. (NASDAQ:CLDX) Suggests It's 34% Undervalued

Apr 21
An Intrinsic Calculation For Celldex Therapeutics, Inc. (NASDAQ:CLDX) Suggests It's 34% Undervalued

Companies Like Celldex Therapeutics (NASDAQ:CLDX) Are In A Position To Invest In Growth

Feb 27
Companies Like Celldex Therapeutics (NASDAQ:CLDX) Are In A Position To Invest In Growth

We're Not Very Worried About Celldex Therapeutics' (NASDAQ:CLDX) Cash Burn Rate

Sep 07
We're Not Very Worried About Celldex Therapeutics' (NASDAQ:CLDX) Cash Burn Rate

Celldex begins dosing in mid-stage study of barzolvolimab for skin disorder

Jul 21

Celldex: Barzolvolimab Plus Bispecific Antibodies Advancement

Jul 14

Celldex Therapeutics (NASDAQ:CLDX) Is In A Good Position To Deliver On Growth Plans

May 25
Celldex Therapeutics (NASDAQ:CLDX) Is In A Good Position To Deliver On Growth Plans

Are Investors Undervaluing Celldex Therapeutics, Inc. (NASDAQ:CLDX) By 31%?

Feb 03
Are Investors Undervaluing Celldex Therapeutics, Inc. (NASDAQ:CLDX) By 31%?

Celldex: Pipeline Of Drug Candidates Is Worth A Look

Feb 01

Celldex Therapeutics: A Best Price-Positioned Biotech Stock As Seen By Market-Makers

Sep 23

We Think Celldex Therapeutics (NASDAQ:CLDX) Can Easily Afford To Drive Business Growth

Sep 15
We Think Celldex Therapeutics (NASDAQ:CLDX) Can Easily Afford To Drive Business Growth

CEO報酬分析

Celldex Therapeutics の収益と比較して、Anthony Marucci の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$154m

Jun 30 2024n/an/a

-US$150m

Mar 31 2024n/an/a

-US$145m

Dec 31 2023US$8mUS$721k

-US$141m

Sep 30 2023n/an/a

-US$125m

Jun 30 2023n/an/a

-US$113m

Mar 31 2023n/an/a

-US$119m

Dec 31 2022US$5mUS$693k

-US$112m

Sep 30 2022n/an/a

-US$106m

Jun 30 2022n/an/a

-US$100m

Mar 31 2022n/an/a

-US$77m

Dec 31 2021US$6mUS$669k

-US$71m

Sep 30 2021n/an/a

-US$72m

Jun 30 2021n/an/a

-US$66m

Mar 31 2021n/an/a

-US$64m

Dec 31 2020US$3mUS$644k

-US$60m

Sep 30 2020n/an/a

-US$48m

Jun 30 2020n/an/a

-US$46m

Mar 31 2020n/an/a

-US$46m

Dec 31 2019US$1mUS$619k

-US$51m

Sep 30 2019n/an/a

-US$50m

Jun 30 2019n/an/a

-US$46m

Mar 31 2019n/an/a

-US$50m

Dec 31 2018US$1mUS$608k

-US$151m

Sep 30 2018n/an/a

-US$146m

Jun 30 2018n/an/a

-US$165m

Mar 31 2018n/an/a

-US$177m

Dec 31 2017US$2mUS$598k

-US$93m

報酬と市場: Anthonyの 総報酬 ($USD 8.36M ) は、 US市場 ($USD 5.57M ) の同規模の企業の平均を上回っています。

報酬と収益: Anthonyの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Anthony Marucci (62 yo)

21.5yrs

在職期間

US$8,361,844

報酬

Mr. Anthony S. Marucci, M.B.A., has been the Chief Executive Officer and President of Celldex Therapeutics Inc. since September 2008. He co-founded Celldex Therapeutics Inc. in 2004. Mr. Marucci served as...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Anthony Marucci
Founder21.5yrsUS$8.36m0.061%
$ 1.1m
Tibor Keler
Founder21.5yrsUS$3.42m0.011%
$ 207.0k
Sam Martin
Senior VP7.3yrsUS$2.95m0.042%
$ 791.4k
Margo Heath-Chiozzi
Senior Vice President of Regulatory Affairs7.1yrsUS$2.94m0.020%
$ 376.6k
Diane Young
Senior VP & Chief Medical Officer5.4yrsUS$2.97m0.026%
$ 481.7k
Joseph Schlessinger
Co-Founder & Member of Scientific Advisory Boardno dataデータなしデータなし
Sarah Cavanaugh
Senior Vice President of Corporate Affairs & Administration7.4yrsデータなし0.0028%
$ 52.3k
Freddy Jimenez
Senior VP & General Counsel3.8yrsUS$2.17m0.053%
$ 997.9k
Ronald Pepin
Chief Business Officer & Senior VP13.3yrsデータなしデータなし
Elizabeth Crowley
Chief Product Development Officer & Senior VP10.3yrsUS$1.18m0.014%
$ 255.4k
Richard Wright
Chief Commercial Officer & Senior VP9.3yrsUS$563.17k0.031%
$ 586.2k

8.4yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: CLDXの経営陣は経験豊富で経験豊富です(平均在職期間は8.4年)。


取締役

名称ポジション在職期間報酬所有権
Anthony Marucci
Founder15.9yrsUS$8.36m0.061%
$ 1.1m
Joseph Schlessinger
Co-Founder & Member of Scientific Advisory Board3.3yrsデータなしデータなし
Harry Penner
Independent Director27.8yrsUS$371.19k0.0042%
$ 78.6k
Herbert Conrad
Independent Director16.7yrsUS$364.94k0.0039%
$ 72.1k
Louis Weiner
Member of Scientific Advisory Boardno dataデータなしデータなし
James Marino
Independent Director7.7yrsUS$377.44k0.0033%
$ 62.0k
Karen Shoos
Independent Chair of the Board of Directors23.5yrsUS$385.77k0.0042%
$ 78.4k
Carl June
Member of Scientific Advisory Boardno dataデータなしデータなし
Michel Nussenzweig
Member of Scientific Advisory Boardno dataデータなしデータなし
Marc Rothenberg
Member of Scientific Advisory Boardno dataデータなしデータなし
Keith Brownlie
Independent Director7.4yrsUS$373.27k0.0010%
$ 18.7k
Cheryl Cohen
Independent Director2.4yrsUS$367.02k0%
$ 0

11.8yrs

平均在職期間

72yo

平均年齢

経験豊富なボード: CLDXの 取締役会 は経験豊富で 経験豊富 です ( 11.8年の平均在任期間)。